APR-2016 : Best Patient-Focused Technological Development at the First Clinical and Research Excellence Awards event, 27 April in Boston.
AARDEX platform winner of the Best Patient-Focused Technological Development
APR-2016 : Best Patient-Focused Technological Development at the First Clinical and Research Excellence Awards event, 27 April in Boston.
AARDEX platform winner of the Best Patient-Focused Technological Development
In a recent paper titled ‘The impacts of undetected nonadherence in phase II, III and post-marketing clinical trials: An overview’ the authors detailed the findings of a research project which aimed to provide an overview of the consequences of unrecognized
Clearly it is in no one’s interests for a clinical trial to fail. Whenever these high-stake activites are abandoned and drug development pathways are aborted, missed opportunities abound. Beyond the sponsor’s missed commercial opportunity, there are missed opportunities to advance